Calyxo
Stub active Updated Apr 19, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
About
Calyxo is a medical device company developing the CVAC System, a platform for kidney stone removal that enables continuous aspiration of stone fragments to support more complete stone clearance 1. As of April 2026, more than 40,000 patients have been treated with the CVAC System 1.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-04-14 | Series F | $40M | Ally Bridge Group, Janus Henderson Investors | Questa Capital, Avidity Partners, CRG 1 |
What Investors Say
No independently sourced investor quotes found.
What Founders Say
No independently sourced founder quotes found.
Sources
-
“Calyxo Secures $40 Million Series F Financing as CVAC System Surpasses 40,000 Patients Treated for Kidney Stone Removal,” Business Wire, April 14, 2026, accessed April 2026. https://www.businesswire.com/news/home/20260414943062/en/Calyxo-Secures-$40-Million-Series-F-Financing-as-CVAC-System-Surpasses-40000-Patients-Treated-for-Kidney-Stone-Removal↩↩↩